NEW YORK (Reuters Health) – Drug-related pneumonitis is a class-effect toxicity of mammalian target of rapamycin (mTOR) inhibitors and temsirolimus is no exception, new research confirms. In the…
NEW YORK (Reuters Health) – Among psychotropic agents administered to elderly patients for behavioral symptoms, atypical antipsychotics are safer than — or at least as safe as —…
WASHINGTON (from The George Washington University) – A new study by The George Washington University School of Medicine and Health Sciences, that will be published in the Journal…
NEW YORK (Reuters Health) – Long-term treatment with the atypical antipsychotic asenapine prevents relapse of schizophrenia and is well tolerated, according to a report in the Journal of…
NEW YORK (Reuters Health) – A review published by the Cochrane Library concludes that artesunate should replace quinine as the standard treatment for severe malaria. Dr. David Sinclair,…
NEW YORK (Reuters Health) – For patients with high platelet reactivity after percutaneous coronary intervention, treatment with a high-dose clopidogrel regimen does not improve outcomes compared with standard…
NEW YORK (Reuters Health) – For reducing pain from venipuncture in newborn infants, oral sucrose is more effective than topical liposomal lidocaine, according to the results of a…
NEW YORK (Reuters Health) – An updated review of medications available for treating type 2 diabetes concludes that metformin continues to have the best benefit-to-harm profile, according to…
NEW YORK (Reuters Health) – Combined with ondansetron and dexamethasone, a single intravenous dose of fosaprepitant is as effective as a standard 3-day oral course of aprepitant for…
NEW YORK (Reuters Health) – Pain associated with diabetic neuropathy is improved to a similar degree with daily amitriptyline or duloxetine, according to the results of a cross-over…